USFDA concludes inspection at Zydus’ LiqMeds in U.K. with four observations
The Hindu

The USFDA has concluded its inspection at Zydus' LiqMeds facility in the U.K. with four observations.
The inspection was conducted from November 9-13, the company said in a
regulatory filing to stock exchanges





